Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mesenchymal stromal/stem cells (MSCs) and MSC-derived extracellular vesicles in COVID-19-induced ARDS: Mechanisms of action, research progress, challenges, and opportunities
Susan Moradinasab, Atieh Pourbagheri‐Sigaroodi, Parisa Zafari, et al.
International Immunopharmacology (2021) Vol. 97, pp. 107694-107694
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Advanced glycation end products (AGEs) and its receptor, RAGE, modulate age-dependent COVID-19 morbidity and mortality. A review and hypothesis
Durai Sellegounder, Parisa Zafari, Misagh Rajabinejad, et al.
International Immunopharmacology (2021) Vol. 98, pp. 107806-107806
Open Access | Times Cited: 55
Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): safety profile assessment
Hamid Reza Aghayan, Fatemeh Salimian, Atefeh Abedini, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 33
Updated Living Systematic Review and Meta-analysis of Controlled Trials of Mesenchymal Stromal Cells to Treat COVID-19: A Framework for Accelerated Synthesis of Trial Evidence for Rapid Approval—FASTER Approval
Aidan M. Kirkham, Adrian Bailey, Madeline Monaghan, et al.
Stem Cells Translational Medicine (2022) Vol. 11, Iss. 7, pp. 675-687
Open Access | Times Cited: 28
Extracellular vesicle-transmitted miR-671-5p alleviates lung inflammation and injury by regulating the AAK1/NF-κB axis
Jie Lian, Xinxing Zhu, Jiang Du, et al.
Molecular Therapy (2023) Vol. 31, Iss. 5, pp. 1365-1382
Open Access | Times Cited: 18
Ramping Up Antimicrobial Peptides Against Severe Acute Respiratory Syndrome Coronavirus-2
Santosh K. Ghosh, Aaron Weinberg
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 37
Extracellular vesicles derived from mesenchymal stem cells ameliorate sulfur mustard-induced lung injury by regulating apoptosis via miR-146a-5p
Zhipeng Pei, Yunrui Sun, Shanshan Zhang, et al.
International Immunopharmacology (2025) Vol. 150, pp. 114285-114285
Closed Access
MSC-mediated mitochondrial transfer promotes metabolic reprograming in endothelial cells and vascular regeneration in ARDS
Jinlong Wang, Shanshan Meng, Yixuan Chen, et al.
Redox Report (2025) Vol. 30, Iss. 1
Open Access
Cellular nanovesicles for therapeutic immunomodulation: A perspective on engineering strategies and new advances
Endong Zhang, Philana Phan, Zongmin Zhao
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 5, pp. 1789-1827
Open Access | Times Cited: 20
Umbilical cord MSC‐derived exosomes improve alveolar macrophage function and reduce LPS‐induced acute lung injury
Enhai Cui, Lu Lv, Bin Wang, et al.
Journal of Cellular Biochemistry (2024) Vol. 125, Iss. 2
Closed Access | Times Cited: 3
COVID-19 immunotherapy: Treatment based on the immune cell-mediated approaches
Mahdi Zavvar, Aisan Yahyapoor, Hamed Baghdadi, et al.
International Immunopharmacology (2022) Vol. 107, pp. 108655-108655
Open Access | Times Cited: 13
Host genetic diversity and genetic variations of SARS-CoV-2 in COVID-19 pathogenesis and the effectiveness of vaccination
Mahda Delshad, Mohammad‐Javad Sanaei, Atieh Pourbagheri‐Sigaroodi, et al.
International Immunopharmacology (2022) Vol. 111, pp. 109128-109128
Open Access | Times Cited: 13
Stem cells as therapeutics and their implications in cytokine storm in COVID-19
Priyanka Surya, Sarika Tomar, R. Pandey, et al.
Elsevier eBooks (2024), pp. 243-253
Closed Access | Times Cited: 2
Mesenchymal Stromal Cell-Derived Extracellular Vesicles as Biological Carriers for Drug Delivery in Cancer Therapy
María Cecilia Sanmartin, Francisco Raúl Borzone, María Belén Giorello, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 11
Intravenous Autologous Bone Marrow–derived Mesenchymal Stromal Cells Delay Acute Respiratory Distress Syndrome in Swine
Andriy I. Batchinsky, Teryn R. Roberts, Ben Antebi, et al.
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 208, Iss. 12, pp. 1283-1292
Closed Access | Times Cited: 6
Immunopathology and Immunosenescence, the Immunological Key Words of Severe COVID-19. Is There a Role for Stem Cell Transplantation?
Mattia Emanuela Ligotti, Fanny Pojero, Giulia Accardi, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 15
Critical signaling pathways governing colitis-associated colorectal cancer: Signaling, therapeutic implications, and challenges
Jiang Xin
Digestive and Liver Disease (2022) Vol. 55, Iss. 2, pp. 169-177
Closed Access | Times Cited: 10
Adipose stromal cells bioproducts as cell-free therapies: manufacturing and therapeutic dose determine in vitro functionality
Renata Škovroňová, Eleonora Scaccia, Sandra Calcat-i-Cervera, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Mesenchymal Stem Cell-Based COVID-19 Therapy: Bioengineering Perspectives
Nihal Karakaş, Süleyman Üçüncüoğlu, Damla Uludağ, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 465-465
Open Access | Times Cited: 8
Mesenchymal stromal cells (MSCs) as a therapeutic agent of inflammatory disease and infectious COVID-19 virus: live or dead mesenchymal?
Ramiar Kamal Kheder, Omeed Darweesh, Bashdar Mahmud Hussen, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Open Access | Times Cited: 1
MSC-Mediated Mitochondrial Transfer Promotes Metabolic Reprogramming in Endothelial Cells and Vascular Regeneration in ARDS
Jinlong Wang, Shanshan Meng, Yixuan Chen, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
The roles, controversies, and combination therapies of autophagy in lung cancer
Zijian Wang, Chunyang Zhou, Shengjie Yang
Cell Biology International (2021) Vol. 46, Iss. 1, pp. 3-11
Closed Access | Times Cited: 9
A Three-Dimensional Xeno-Free Culture Condition for Wharton’s Jelly-Mesenchymal Stem Cells: The Pros and Cons
Benson Koh, Nadiah Sulaiman, Mh Busra Fauzi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3745-3745
Open Access | Times Cited: 3
The role and therapeutic applications of exosomes in multiple sclerosis disease
Khalil Komlakh, Seyed Hossein Aghamiri, Hossein Farshadmoghadam
Clinical and Experimental Pharmacology and Physiology (2022) Vol. 49, Iss. 12, pp. 1249-1256
Closed Access | Times Cited: 3
Мезенхімальні стовбурові клітини — головний ресурс клітинної терапії. Використання для лікування цукрового діабету
М.D. Тronko, V.M. Pushkarev, О.I. Kovzun, et al.
Endokrynologia (2022) Vol. 27, Iss. 3, pp. 214-235
Closed Access | Times Cited: 3
Synergistic therapeutic approach for hemorrhoids: integrating mesenchymal stem cells with diosmin-hesperidin to target tissue edema and inflammation
M. Hidayat Budi Kusumo, Adi Prayitno, Soetrisno, et al.
Archives of Medical Science (2024)
Open Access
Page 1 - Next Page

Scroll to top